id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0074-0025,FDA,FDA-2011-D-0074,Guidance for Industry on Medication Guide Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies,Other,Guidance,2011-11-18T05:00:00Z,2011,11,2011-11-18T05:00:00Z,,2024-11-11T21:37:13Z,,1,0,0900006480f6f37a
FDA-2011-D-0074-0024,FDA,FDA-2011-D-0074,Guidance for Industry on Medication Guide Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies; Availability,Notice,Notice of Data Availability,2011-11-18T05:00:00Z,2011,11,2011-11-18T05:00:00Z,,2019-10-21T13:22:31Z,2011-29877,0,0,0900006480f6f567
FDA-2011-D-0074-0001,FDA,FDA-2011-D-0074,Draft Guidance for Industry on Medication Guides; Availability: Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies,Notice,NAD-Notice of Availability of Data,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,2011-06-01T03:59:59Z,2011-02-28T15:21:37Z,2011-04341,0,0,0900006480bfa5f8
FDA-2011-D-0074-0002,FDA,FDA-2011-D-0074,Draft Guidance for Industry - Medication Guides; Distribution Requirements and Inclusion of Medication Guides in Risk Evaluation and Mitigation Strategies (REMS),Other,GDL-Guidance,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2019-10-21T13:22:59Z,,0,0,0900006480bfa33c